Literature DB >> 9010282

Characterization of monoclonal antibody-escape mutants of tick-borne encephalitis virus with reduced neuroinvasiveness in mice.

H Holzmann1, K Stiasny, M Ecker, C Kunz, F X Heinz.   

Abstract

Escape mutants of tick-borne encephalitis (TBE) virus were selected using neutralizing monoclonal antibodies (MAbs) that react with three different and previously unrecognized epitopes in the envelope protein E of TBE virus. Two of these variants (V-IC3 and V-IE3) exhibited a significantly reduced reactivity with their selecting MAbs, as determined by ELISA, whereas with one variant (V-IO3), reactivity was completely unchanged. Comparative sequence analyses demonstrated that each of the variants differed from the wild-type virus by a single amino acid substitution located at exposed positions within domains I, II and III of protein E. In the mouse model, all three mutants were still neuro-virulent but exhibited a significantly reduced neuro-invasiveness after subcutaneous inoculation. Virus replication, however, was sufficient to induce a specific antibody response. The observed alterations in virulence properties were not associated with reduced growth rates in vertebrate cell cultures, but one variant (V-IE3) exhibited a small plaque phenotype. The mutation of variant V-IO3 resulted in a temperature-sensitive phenotype and a significant elevation of the pH-threshold of the conformational change necessary for fusion activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9010282     DOI: 10.1099/0022-1317-78-1-31

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  28 in total

1.  Capsid protein C of tick-borne encephalitis virus tolerates large internal deletions and is a favorable target for attenuation of virulence.

Authors:  Regina M Kofler; Franz X Heinz; Christian W Mandl
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Spontaneous mutations restore the viability of tick-borne encephalitis virus mutants with large deletions in protein C.

Authors:  Regina M Kofler; Agnes Leitner; Gabriel O'Riordain; Franz X Heinz; Christian W Mandl
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo.

Authors:  C W Mandl; H Kroschewski; S L Allison; R Kofler; H Holzmann; T Meixner; F X Heinz
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

4.  Impact of quaternary organization on the antigenic structure of the tick-borne encephalitis virus envelope glycoprotein E.

Authors:  Stefan Kiermayr; Karin Stiasny; Franz X Heinz
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

5.  Proteolytic activation of tick-borne encephalitis virus by furin.

Authors:  K Stadler; S L Allison; J Schalich; F X Heinz
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

6.  Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge.

Authors:  C Schmaljohn; L Vanderzanden; M Bray; D Custer; B Meyer; D Li; C Rossi; D Fuller; J Fuller; J Haynes; J Huggins
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

7.  Recombinant measles viruses expressing altered hemagglutinin (H) genes: functional separation of mutations determining H antibody escape from neurovirulence.

Authors:  K Moeller; I Duffy; P Duprex; B Rima; R Beschorner; S Fauser; R Meyermann; S Niewiesk; V ter Meulen; J Schneider-Schaulies
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

8.  Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).

Authors:  J Arroyo; F Guirakhoo; S Fenner; Z X Zhang; T P Monath; T J Chambers
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

9.  A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites.

Authors:  Cheng-Wen Lin; Suh-Chin Wu
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  Epitope determinants of a chimpanzee dengue virus type 4 (DENV-4)-neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody.

Authors:  Ching-Juh Lai; Ana P Goncalvez; Ruhe Men; Claire Wernly; Olivia Donau; Ronald E Engle; Robert H Purcell
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.